Medicine and HealthNature Communications
Antibodies targeting the Crimean-Congo Hemorrhagic Fever Virus nucleoprotein protect via TRIM21
S. S. Leventhal, T. Bisom, et al.
Discover groundbreaking research on the Crimean-Congo Hemorrhagic Fever Virus, revealing how a self-replicating RNA vaccine induces neutralizing antibodies and protective immunity through TRIM21. This exciting study by Shanna S Leventhal and colleagues sheds new light on the mechanisms of protection against this lethal virus.
Related Publications
Explore these studies to deepen your understanding
Adjacent work that informs or extends this paper's methodology and findings.
Health and Fitness
Risk of yellow fever virus transmission in the Asia-Pacific region
L. D. G. D. Lataillade, M. Vazeille, et al.
Medicine and Health
Targeting the coronavirus SARS-CoV-2: computational insights into the mechanism of action of the protease inhibitors lopinavir, ritonavir and nelfinavir
G. Bolcato, M. Bissaro, et al.
Economics
Does the growth of military hard power back up the growth of monetary soft power via data-driven probabilistic optimal relations?
R. Chen
Social Work
The Zika virus crisis during the 2016 Rio Olympic Games: a media cover analysis
D. R. Toubes, J. Á. D. L. Torre, et al.
